Todd C Davis

Director Todd C Davis purchases 35,948 shares for $999,983.28 at blended average $27.82 despite current price $26.50.

Todd C Davis acquired 35,948 shares across 2 separate purchases totaling $999,983.28 at a blended average price of $27.82, occurring on 2026-06-11 when the stock was trading approximately $27.80–$28.73. The purchase doubled his holdings from 39,886 shares to 75,834 shares (+90.1%), representing a substantial personal capital commitment of approximately one million dollars in a company with recent quarterly revenue of $10,906,000 and negative net income of $-10,238,000. The transaction occurred when the current price of $26.50 is down 51.2% from the 52-week high of $54.29, and the stock has declined 0.8% over the past 30 days despite a +11.1% gain over 90 days. Across his cross-ticker open-market history, Davis demonstrates a 100% win rate on prior buys over the 90-day horizon (5 prior transactions averaging +31.5% return), though this specific company is unprofitable and the recent buying price sits materially above current levels.

CEO Davis Todd C bought 9,510 shares of LGND for $1,000,456.38 across 3 transactions on 2025-05-09, lifting holdings to 161,234 shares (+6.3%)

Davis Todd C, CEO of Ligand Pharmaceuticals, executed 3 separate purchases totaling 9,510 shares for $1,000,456.38 at a blended average price of $105.20 on 2025-05-09. His prior two open-market buys at this ticker were well-timed at the 90-day mark (delivering +20.0% and +19.3% returns respectively), establishing a pattern of purchases made near local lows. The current share price of $105.63 is -18.7% below the 52-week high of $129.90, and the company reported a net loss of $-42,451,000.00 against quarterly revenue of $45,333,000.00, though annual revenue grew +27.3%. This buy adds 9,510 shares (+6.3%) to his post-transaction holdings of 161,234 shares, signaling continued confidence in the business despite near-term profitability headwinds and current valuation proximity to recent transaction prices.

CEO Todd Davis bought 2,500 LGND shares at $97.39 on Aug 8; stock now at $100.16 vs $49.57-$110.11 52-week range

CEO Davis Todd C acquired 2,500 shares for $243,480.50, increasing his holdings to 123,010 shares post-transaction. The purchase occurred at $97.39, near the upper end of the 52-week range ($49.57–$110.11), with the stock currently at $100.16 (+4.0% over 30 days, +14.8% over 90 days). His prior open-market buy at this ticker (2023-09-22) showed a +19.3% 90-day return, indicating a historical pattern of well-timed accumulation at LGND. However, the company faces material headwinds: revenue contracted 33.1% year-over-year, latest quarterly revenue sits at $41.5M, and net income is -$51.9M, reflecting significant operational strain. The timing and price point warrant attention given the fundamental deterioration versus the stock's recent rally.